MDWDNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
MediWound Ltd.
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 5, 2026
$12.70+0.85 (+7.17%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
MediWound statistics
Financials through Dec 31, 2025, price as of Oct 19, 2026, median of Medicinal Chemicals & Botanical Products companies for comparison
Valuation
| Measure | MediWound | Industry median |
|---|---|---|
| Market Cap | $163.01M | $166.30M |
| Enterprise Value | $158.21M | $87.12M |
| PS Ratio | 9.61 | 3.60 |
Enterprise value
| Measure | MediWound | Industry median |
|---|---|---|
| EV / Sales | 9.33 | 2.43 |
Income (trailing twelve months)
| Measure | MediWound | Industry median |
|---|---|---|
| Revenue | $16.96M | $57.94M |
| Gross Profit | $3.25M | $90.47M |
| Operating Income | -$25.27M | -$21.49M |
| Pretax Income | -$23.71M | -$14.72M |
| EBITDA | -$23.41M | -$17.14M |
| EPS (Diluted) | -$2.10 | -$0.83 |
Margins
| Measure | MediWound | Industry median |
|---|---|---|
| Gross Margin | 19.2% | 52.3% |
| Operating Margin | -149.0% | -44.5% |
| Pretax Margin | -139.8% | -13.0% |
| EBITDA Margin | -138.0% | -31.3% |
| FCF Margin | -127.5% | -8.85% |
Returns
| Measure | MediWound | Industry median |
|---|---|---|
| Return on Capital Employed (ROCE) | -41.7% | -38.0% |
Growth
| Measure | MediWound | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -16.1% | 6.01% |
| Revenue Growth (3Y CAGR) | -13.8% | 2.25% |
| Revenue Growth (5Y CAGR) | -4.87% | 6.42% |
Balance sheet
| Measure | MediWound | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $4.80M | $62.64M |
| Net Cash (Debt) | $4.80M | $15.77M |
| Net Cash Per Share | $0.37 | $0.66 |
| Working Capital | $34.26M | $75.09M |
Financial position
| Measure | MediWound | Industry median |
|---|---|---|
| Current Ratio | 2.33 | 3.30 |
| Quick Ratio | 0.25 | 2.39 |
| Interest Coverage | -10.27 | -7.12 |
Cash flow (trailing twelve months)
| Measure | MediWound | Industry median |
|---|---|---|
| Operating Cash Flow | -$16.12M | -$12.39M |
| Capital Expenditures | -$5.51M | -$1.07M |
| Free Cash Flow | -$21.63M | -$20.34M |
| FCF Per Share | -$1.68 | -$0.42 |
Efficiency
| Measure | MediWound | Industry median |
|---|---|---|
| Asset Turnover | 0.21 | 0.38 |
| Inventory Turnover | 4.04 | 2.67 |
| Revenue Per Employee | $484.54K | $398.96K |
| Employee Count | 35 | 74 |
Dividends and yields
| Measure | MediWound | Industry median |
|---|---|---|
| FCF Yield | -13.3% | -9.02% |
Shares
| Measure | MediWound | Industry median |
|---|---|---|
| Shares Outstanding | 12,835,100 | 58,139,000 |
| Shares Change (YoY) | 14.2% | 11.1% |
| Float | 9,909,470 | 49,154,900 |
| Shares Held by Insiders | 22.8% | 11.6% |
Taxes
| Measure | MediWound | Industry median |
|---|---|---|
| Income Tax | $169.00K | $89.00K |
Scores
| Measure | MediWound | Industry median |
|---|---|---|
| Altman Z-Score | -1.71 | -0.27 |
| Beneish M-Score | -3.78 | -2.62 |
Calculated by StockData from MediWound's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.